You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

CLINICAL TRIALS PROFILE FOR TECARFARIN


✉ Email this page to a colleague

« Back to Dashboard


Clinical Trials for Tecarfarin

Trial ID Title Status Sponsor Phase Summary
NCT02522221 ↗ Tecarfarin Anti-Coagulation Trial (TACT) Unknown status Armetheon Inc Phase 3 TACT is a "real world" randomized controlled trial of tecarfarin, a novel vitamin K antagonist, vs. warfarin. The quality of anticoagulation control will be compared for the two groups of subjects who require chronic oral anticoagulation for a broad panel of indications.
NCT02522221 ↗ Tecarfarin Anti-Coagulation Trial (TACT) Unknown status Espero Biopharma Phase 3 TACT is a "real world" randomized controlled trial of tecarfarin, a novel vitamin K antagonist, vs. warfarin. The quality of anticoagulation control will be compared for the two groups of subjects who require chronic oral anticoagulation for a broad panel of indications.
NCT03652779 ↗ A Study to Evaluate the Safety and Tolerability of Tecarfarin in Healthy Chinese Volunteers Completed Lee's Pharmaceutical Limited Phase 1 The purpose of the study is to evaluate the safety and tolerability of a single dose of tecarfarin in healthy Chinese Volunteers. the Pharmacokinetic and pharmacodynamic profile of tecarfarin will also be evaluated.
NCT04627116 ↗ An Ascending, Multiple-Dose, Safety and Tolerability Study of Tecarfarin in Healthy Chinese Volunteers Enrolling by invitation Lee's Pharmaceutical Limited Phase 1 The subjects will be admitted to the Phase I Clinical Research Center on day -1. Subjects received once-daily doses of Tecarfarin for up to 14 days.Subjects can leave the Phase I Clinical Research Center on the day 21.And returned to the research center for follow-up on the day 28 and 35.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for Tecarfarin

Condition Name

Condition Name
Intervention Trials
Healthy Chinese Volunteers 1
Pharmacokinetic and Pharmacodynamic Profile of Tecarfarin 1
Thromboembolism 1
Thrombosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH
Intervention Trials
Thrombosis 1
Thromboembolism 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Tecarfarin

Trials by Country

Trials by Country
Location Trials
China 1
Hong Kong 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Tecarfarin

Clinical Trial Phase

Clinical Trial Phase
Clinical Trial Phase Trials
Phase 3 1
Phase 1 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status
Clinical Trial Phase Trials
Completed 1
Enrolling by invitation 1
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Tecarfarin

Sponsor Name

Sponsor Name
Sponsor Trials
Lee's Pharmaceutical Limited 2
Armetheon Inc 1
Espero Biopharma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type
Sponsor Trials
Industry 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.